# OnCo record dantari (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/dantari/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "dantari" ;
  schema:name "Dantari"@en ;
  schema:description "Dantari built polymer-based drug carriers that let an antibody deliver far more chemotherapy to a tumour than standard antibody-drug conjugates, while sparing the bone marrow. Its first medicine was tested in breast cancer before the company sold off its assets in 2025."@en ;
  schema:url <https://onco.cc/companies/dantari/>, <https://dantari.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://dantari.com/>, <https://www.prnewswire.com/news-releases/dantari-debuts-with-47-million-series-a-to-advance-best-in-class-targeted-medicines-for-solid-tumors-301697300.html>, <https://endpoints.news/boehringer-merges-cancer-vaccine-and-oncolytic-virus-teams-dantari-sells-off-assets/> ;
  schema:addressCountry "US" ;
  onco:related <https://onco.cc/collections/src-endpoints-news/> ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/> ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/her2/> .